FDA Inspection 1108759 — Anuj Bhargava MD
The FDA completed an inspection of Anuj Bhargava MD on September 27, 2019 in West Des Moines, IA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- September 27, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- West Des Moines, IA (United States)
Additional Details
Clinical Investigator (CI)